SubHero Banner
Text

November 2021

Core topics in this month’s edition include:

  • Semglee (insulin glargine-yfgn) –  interchangeable biosimilar to Lantus (insulin glargine)
  • COVID-19 Vaccines – Emergency use authorization expansion
  • Voxzogo (vosoritide) – new orphan drug approval

Download PDF

Text